No Data
i-mab (IMAB.US) appoints Sean Fu as the company's Chief Executive Officer.
i-mab (IMAB.US) announced today that Dr. Sean (Xi-Yong) Fu, PhD, MBA, has been officially appointed as the Chief Executive Officer ("CEO") of the company, effective November 1, 2024. Dr. Fu has been serving as the interim CEO since July 15, 2024, and will continue as a member of the board of directors of I-Mab.
Express News | I-Mab - Appoints Sean Fu as CEO
Express News | I-Mab - on Nov 1 Federal Jury Found in Favor of Defendants in Bifurcated Trial Relating to Some of Co's Trade Secret Information
Express News | Inhibrx Biosciences Inc: Legal Victory in a Trade Secrets Case Brought by I-Mab Biopharma
I-Mab to Release Q3 2024 Financial Results on November 14, 2024
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
No Data
No Data